{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:29:42Z","timestamp":1793806182767,"version":"4.6.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"39","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Coronary artery disease (CAD) remains a major cause of morbidity and mortality worldwide. Although guideline-directed Western medical therapy improves cardiovascular outcomes, residual symptoms remain common. Integrated traditional Chinese and Western medicine is frequently used as an adjunctive strategy in China, but its real-world, short-term clinical associations require further characterization. This retrospective observational study included 215 patients with CAD treated between January 2022 and December 2024, including 106 patients receiving conventional Western medical therapy alone and 109 receiving adjunctive traditional Chinese medicine based on syndrome differentiation. Symptom status, laboratory parameters, overall clinical response, and documented adverse events were compared between groups. Because treatment allocation was nonrandom and the analyses were unadjusted for potential confounders, all between-group findings were interpreted as associations. No statistically significant differences were observed in the measured baseline demographic, clinical, or laboratory characteristics between the 2 groups. After treatment, the integrated-treatment group had lower rates of residual chest pain, chest tightness, and fatigue and greater changes in total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fibrinogen, and D-dimer. The observed overall clinical response rate was higher in the integrated-treatment group (90.8% vs 76.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.004). Documented adverse-event incidence did not differ significantly between groups. In this retrospective real-world cohort, adjunctive traditional Chinese medicine was associated with greater short-term improvement in selected symptoms and laboratory parameters and a higher observed clinical response rate, without a detectable increase in documented short-term adverse events. These unadjusted observational findings are exploratory, do not establish causal superiority or improved cardiovascular prognosis, and are insufficient by themselves to modify current guideline-directed CAD practice.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050810","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:02:14Z","timestamp":1790359334000},"page":"e50810","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical efficacy of integrated traditional Chinese and Western medicine in patients with coronary artery disease"],"prefix":"10.1097","volume":"105","author":[{"given":"Ziyi","family":"Chai","sequence":"first","affiliation":[{"name":"The First Clinical College of Shanxi University of Chinese Medicine, The Affiliated Hospital of Shanxi University of Chinese Medicine, Jinzhong, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2067-9097","authenticated-orcid":false,"given":"Huaying","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Shanxi Provincial People\u2019s Hospital, Taiyuan, Shanxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261104","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes.","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"R2-20261104","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.mcna.2023.11.004","article-title":"Optimal medical therapy for chronic coronary disease in 2024: focus on antithrombotic therapy.","volume":"108","author":"Patel","year":"2024","journal-title":"Med Clin North Am"},{"key":"R3-20261104","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/heartjnl-2024-325408","article-title":"Inflammation in coronary atherosclerosis: diagnosis and treatment.","volume":"111","author":"Occhipinti","year":"2025","journal-title":"Heart"},{"key":"R4-20261104","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000537706","article-title":"Antithrombotic treatment for chronic coronary syndrome: evidence and future perspectives.","volume":"149","author":"Kulasingam","year":"2024","journal-title":"Cardiology"},{"key":"R5-20261104","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.clinthera.2014.08.010","article-title":"Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.","volume":"36","author":"Thompson","year":"2014","journal-title":"Clin Ther"},{"key":"R6-20261104","doi-asserted-by":"crossref","first-page":"155579","DOI":"10.1016\/j.phymed.2024.155579","article-title":"Characteristics and efficacy of traditional Chinese medicine in the therapeutic strategy of chronic coronary syndrome: a systematic review and meta-analysis.","volume":"129","author":"Ma","year":"2024","journal-title":"Phytomedicine"},{"key":"R7-20261104","doi-asserted-by":"crossref","first-page":"1229299","DOI":"10.3389\/fcvm.2024.1229299","article-title":"Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis.","volume":"11","author":"Li","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R8-20261104","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2147\/TCRM.S511630","article-title":"Exploring the complementary role of traditional chinese medicine in enhancing percutaneous coronary intervention outcomes: mechanisms, benefits, and future research directions.","volume":"21","author":"Zheng","year":"2025","journal-title":"Ther Clin Risk Manag"},{"key":"R9-20261104","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines.","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"R10-20261104","doi-asserted-by":"crossref","first-page":"1194082","DOI":"10.3389\/fcvm.2023.1194082","article-title":"Integrated Chinese and Western medicine for stable angina pectoris of coronary heart disease: a real-world study including 690 patients.","volume":"10","author":"Yu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R11-20261104","doi-asserted-by":"crossref","first-page":"1375795","DOI":"10.3389\/fphar.2024.1375795","article-title":"Effects of modified Danggui Sini Decoction as adjuvant therapy for angina pectoris in coronary heart disease: a systematic review and meta-analysis based on randomised controlled trials.","volume":"15","author":"Wang","year":"2024","journal-title":"Front Pharmacol"},{"key":"R12-20261104","doi-asserted-by":"crossref","first-page":"1407536","DOI":"10.3389\/fcvm.2024.1407536","article-title":"Traditional Chinese medicine lowering lipid levels and cardiovascular events across baseline lipid levels among coronary heart disease: a meta-analysis of randomized controlled trials.","volume":"11","author":"Xie","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R13-20261104","doi-asserted-by":"crossref","first-page":"1091718","DOI":"10.3389\/fphar.2023.1091718","article-title":"The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: an updated meta-analysis of 27 randomized controlled trials.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"R14-20261104","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41569-026-01250-6","article-title":"Procoagulant platelets: linking coagulation and thromboinflammation in cardiovascular disease.","volume":"23","author":"Kaiser","year":"2026","journal-title":"Nat Rev Cardiol"},{"key":"R15-20261104","doi-asserted-by":"crossref","first-page":"1586265","DOI":"10.3389\/fphar.2025.1586265","article-title":"Systematic analysis of the interaction mechanism between platelets and coronary heart disease: from molecular pathways to new strategies for plant based antiplatelet therapy.","volume":"16","author":"Liao","year":"2025","journal-title":"Front Pharmacol"},{"key":"R16-20261104","first-page":"1656","article-title":"The multifaceted role of platelets in atherosclerosis and ischemic disease: pathogenesis, inflammation, and therapeutic opportunities.","volume":"15","author":"Strukel","year":"2025","journal-title":"Life (Basel)"},{"key":"R17-20261104","doi-asserted-by":"crossref","first-page":"824112","DOI":"10.3389\/fcvm.2021.824112","article-title":"Neutrophil-platelet interactions as novel treatment targets in cardiovascular disease.","volume":"8","author":"Kaiser","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R18-20261104","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1002\/ptr.70037","article-title":"An up-to-date review of traditional chinese medicine in the treatment of atherosclerosis: components, mechanisms, and therapeutic potentials.","volume":"39","author":"Nijat","year":"2025","journal-title":"Phytother Res"},{"key":"R19-20261104","doi-asserted-by":"crossref","first-page":"157994","DOI":"10.1016\/j.phymed.2026.157994","article-title":"Real-world applications of integrated traditional Chinese and Western medicine in patients with intermediate coronary lesions: Insights from a multicenter observational cohort study.","volume":"154","author":"Wang","year":"2026","journal-title":"Phytomedicine"},{"key":"R20-20261104","first-page":"401","article-title":"Efficacy and safety of Yi\u2019anning pills for stable angina pectoris in coronary heart disease with Qi-blood and liver-kidney deficiency syndrome: a multicenter, randomized, double-blind, superiority clinical trial.","volume":"46","author":"Li","year":"2026","journal-title":"J Tradit Chin Med"},{"key":"R21-20261104","doi-asserted-by":"crossref","first-page":"1619928","DOI":"10.3389\/fcvm.2026.1619928","article-title":"The effects of traditional Chinese Medicine on cardiac function after percutaneous coronary intervention: a meta-analysis and systematic review.","volume":"13","author":"Wang","year":"2026","journal-title":"Front Cardiovasc Med"},{"key":"R22-20261104","doi-asserted-by":"crossref","first-page":"121377","DOI":"10.1016\/j.jep.2026.121377","article-title":"Comparative efficacy and safety of Chinese patent medicines in coronary heart disease patients after percutaneous coronary intervention: a systematic review and network meta-analysis.","volume":"363","author":"Wang","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"R23-20261104","doi-asserted-by":"crossref","first-page":"121763","DOI":"10.1016\/j.jep.2026.121763","article-title":"Traditional Chinese medicine in coronary heart disease: a review of advances and therapeutic strategies.","volume":"368","author":"Shi","year":"2026","journal-title":"J Ethnopharmacol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:02:35Z","timestamp":1793804555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":23,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050810","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"2026-04-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}